James Fund for Life

In 2002, Abigail and Les Wexner launched The James Fund for Life — the first annual fund campaign supporting leading-edge research, clinical trials and technology at the OSUCCC – James.

Past James Fund for Life Acquisitions

2016 Tomosynthesis Technology

Tomosynthesis is a 3D imaging technology that acquires images of a breast at multiple angles during a short scan. These are used to produce a series of images that can be viewed as a 3D reconstruction of the breast.

2015 NextSeq 500 Sequencing System

The NextSeq™ 500 Sequencing System from Illumina, a California-based company that is a fast, flexible, high-throughput desktop sequencer that offers a range of applications with the accuracy of sequencing-by-synthesis (SBS) technology.

2009 – 2014

Funding for technology in the new James Cancer Hospital and Solove Research Institute.

2008 Flow Cytometer

This sophisticated instrument enables medical scientists to rapidly measure physical and chemical properties of cells and particles. Flow cytometers, which consist of electrical, digital and optical components, allow for accurate analysis of DNA, cell cycle, cell function and cell death. This analysis is of paramount importance in helping scientists understand the basic properties of cancer in its many forms.

2007 Digital Mobile Mammography Unit & Funds for Technology Needs of the New Survivorship Center

The addition of this new, high-tech mobile unit with digital mammogram capabilities to the JamesCare comprehensive breast program greatly enhances our ability to identify and treat breast cancer in the Columbus region and provides the opportunity to reach areas of Ohio that do not have easy access to mammography.

2006 Robotic Surgical Equipment — daVinci Robot

The OSUCCC – James has become a leader in robotic surgery, impacting surgeons and patients around the world. The first robot was in high demand, and the 2006 gift allowed the OSUCCC – James to add a second robot to its surgical lineup, giving patients and doctors more access to the latest surgical technology.

2005 Stereotactic Radiosurgery & Image-Guided Radiation Therapy

This technology provides nonsurgical treatment to tumor sites outside the brain with pinpoint accuracy to reduce damage to healthy tissue. The equipment complements the Division of Radiation Oncology’s existing stereotactic radiosurgery program, which currently treats only brain tumors.

2004 Robotic Surgical Equipment & Technology

With the acquisition of this technology, the OSUCCC – James successfully recruited world-class experts to its robotics and minimally invasive urological surgery program. Surgeons have been able to perform procedures with greater precision and dexterity, allowing patients to recover more quickly, with minimal pain and an earlier return to normal activity.

2003 Intra-Operative MRI System

The physicians of the neurological surgery department are able to better diagnose and treat certain types of cancer with this intra-operative technology unlike any other in central Ohio. This system provides a valuable adjunct to standard neurological care, allowing the surgeon full access to the patient and providing state-of-the-art imaging during surgery.

2002 PET/CT Scanner

The acquisition of a Siemens PET/CT scanner combined the imaging technologies of positron emission tomography (PET) and computer tomography (CT) to offer the ultimate imaging performance for improved diagnosis and treatment in oncology, neurology and cardiology.